# Phase II, Dose Finding Study of GTx-758

> **NCT01393119** · PHASE2 · TERMINATED · sponsor: **GTx** · enrollment: 77 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** GTx-758

## Key facts

- **NCT ID:** NCT01393119
- **Lead sponsor:** GTx
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-08
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 77 (ACTUAL)
- **Why stopped:** FDA Clinical Hold
- **Last updated:** 2024-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01393119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01393119, "Phase II, Dose Finding Study of GTx-758". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01393119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*